A rapid HPLC method for the quantification of 3,5,4 '-trimethoxy-trans-stilbene (TMS) in rat plasma and its application in pharmacokinetic study

作者：Lin Hai Shu^*; Ho Paul C

来源：Journal of Pharmaceutical and Biomedical Analysis, 2009, 49(2): 387-392.

DOI：10.1016/j.jpba.2008.10.042

• 3,5,4 '-trimetlioxy-tratis-stilbene
• HPLC
• UV detection
• Pharmacokinetics

A rapid HPLC-UV method had been developed and validated to quantify 3,5,4'-trimethoxy-trans-stilbene (TMS), a naturally occurring and pharmacologically active analog of resveratrol in rat plasma. The samples were mixed with three volumes of acetonitrile to precipitate protein. Chromatographic separation was achieved on a RP-HPLC column (Agilent ZORBAX Eclipse Plus C18: 250 mm x 4.6 mm i.d., 5 mu m), which was protected by a guard column (Agilent ZORBAX Eclipse Plus C18: 12.5 mm x 4.6 mm W., 5 km) through isocratic delivery of a mobile phase of acetonitrile: water (75:25, v/v) at a flow rate of 1.2 ml/min. The assay was executed at 30,C and the UV absorbance at 320 nm was monitored. The retention time of TMS and trans-stilbene (internal standard) was 6.5 and 8.3 min, respectively. The calibration curve was linear within the range of 15-1000 ng/ml (R(2) > 0.998) and 15 ng/ml was the lower LOQ. The intra- and inter-day precisions were good and the RSD was all lower than 7.3%. The mean absolute recovery of TMS in plasma ranged from 99.2 to 104.1%. This HPLC method had been successfully applied to study the pharmacokinetics of TMS, which was fully dissolved with hydroxypropyl-p-cyclodextrin (HP-beta-CyD). In comparison with resveratrol, TMS had greater plasma exposure, longer elimination half-life and lower clearance. As TMS had superior pharmacokinetic characteristics, its potential as a preventive or therapeutic agent in resveratrol-effective conditions or diseases should be considered.

• 出版日期2009-2-20